Abstract:Abstract Background: Heart failure (HF) is a prevalent global health issue with increasing incidence due to aging populations and advancements in treatment. The Cardiometabolic Index (CMI), a new marker combining waist-to-height ratio and the triglycerides-to-HDL cholesterol ratio, has shown promise in predicting cardiovascular risks. However, the relationship between CMI and HF remains unclear, warranting further investigation. This study aims to examine the association between CMI and HF to better understand and potentially identify HF risks. Methods: This study included 101,316 participants, of whom 22,042 met the selection criteria to investigate the correlation between the CMI and heart failure. The CMI is calculated as the product of the waist-to-height ratio (WHtR) and the triglycerides-to-HDL cholesterol ratio (TG/HDL-C). Data collection involved personal interviews to gather heart failure information, with HF diagnosis based on specific questionnaire responses. Clinical and biochemical data encompassed a wide range of variables, including demographic details, health status, and biochemical markers. Statistical analyses leveraged complex survey design from the National Health and Nutrition Examination Survey (NHANES), using weighted regression and chi-square tests to compare groups and multivariate logistic regression to examine the CMI-HF relationship across adjusted models. An analysis of the threshold effect elucidated the nonlinear dynamics present between CMI and HF, incorporating subgroup analyses to investigate the interactions among variables and the Receiver Operating Characteristic (ROC) curve was employed to evaluate the diagnostic utility of CMI in comparison to Body Mass Index (BMI) for the detection of HF. Results: In this study, based on specific inclusion and exclusion criteria, 706 individuals were diagnosed with HF, representing 3.2% of the total population. The findings indicated a significant association between elevated CMI levels and an increased risk of HF (OR = 1.13; 95% CI, 1.07–1.17, p < 0.001), with each unit increment in CMI level being associated with a 13% increase in HF risk. Subgroup analyses revealed the stability of the CMI-HF relationship across various subgroups, identifying race, history of heart disease, and hypertension status as key modulators of the strength and direction of the CMI-HF association. Moreover, smooth curve fitting and threshold effect analysis demonstrated a non-linear relationship between CMI and HF, with an inflection point at a CMI level of 6.49. Below this threshold, the incidence of HF increased with rising CMI levels. Additionally, the diagnostic capabilities of CMI and Body Mass Index (BMI) in identifying HF were compared, with the area under the curve (AUC) values for CMI surpassing those for BMI, indicating a superior ability of CMI in identifying HF. Conclusion: Our research indicates that the level of CMI bears a substantial positive correlation with the incidence risk of HF, with the relationship between CMI and HF being non-linear. Additionally, the CMI is a better predictor of HF than the BMI.

Obesity, subclinical myocardial injury, and incident heart failure

High Burden of Subclinical and Cardiovascular Disease Risk in Adults With Metabolically Healthy Obesity: The Atherosclerosis Risk in Communities (ARIC) Study

Elevated circulating high-sensitivity cardiac troponin t and cardiac remodeling in obesity

Obesity and subtypes of incident cardiovascular disease

Abstract 37: Proteomic Signatures of Obesity-Related Heart Failure in the Atherosclerosis Risk in Communities (ARIC) Study

High-sensitivity cardiac troponin T and risk of hypertension

Clinical Implications of High-Sensitivity Troponin Elevation Levels in Non-ST-Segment Elevation Myocardial Infarction Patients: Beyond Diagnostics

Increased circulating High-Sensitivity Troponin T concentrations in children and adolescents with obesity and the metabolic syndrome: A marker for early cardiac damage?

Association of High-Sensitivity Cardiac Troponin T with All-Cause and Cardiovascular Mortality in Older Adults with Low Lean Mass: A 14.6-Year Longitudinal Study.

Impaired Metabolic Health and Low Cardiorespiratory Fitness Independently Associate With Subclinical Atherosclerosis in Obesity

Adiposity and incident heart failure and its subtypes: MESA (Multi-Ethnic Study of Atherosclerosis)

Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study

Abstract 13938: Anthropometric Measures vs. CT-Measures of Adiposity and Risk of Incident Heart Failure With Preserved Ejection Fraction: The Multi-Ethnic Study of Atherosclerosis (MESA)

High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study

Associations between Cardiometabolic Index and heart failure in adults aged ≥ 20 years: Evidence from the NHANES 1999–2018

Abstract EP43: Obesity And Incident Cardiovascular Disease (CVD): The Jackson Heart Study

N-terminal pro-brain natriuretic peptide and heart failure risk among individuals with and without obesity: the Atherosclerosis Risk in Communities (ARIC) Study

High-Sensitivity Troponin-T and heart failure risk in individuals with suspected acute coronary syndrome

Proteomic Signature of BMI and Risk of Cardiovascular Disease

Association of Weight and Body Composition on Cardiac Structure and Function in the ARIC Study (Atherosclerosis Risk in Communities)

Myocardial Tissue-Level Characteristics of Adults With Metabolically Healthy Obesity